Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000266

Drug Information
NameZaleplon
SynonymsZINC00006300; Sonata; 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide; CL 284846; CHEMBL1521; ZAL-846; D00530; AZ-007; HMS2052J11; CL284,846; zaleplon; LS-8737; Acetamide, N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethyl-; TL8001114; BIDD:GT0046; 3'-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide; N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide; LS-173402; SAM001246641; MLS000759451; Sonata (TN); LJC 10846; CL 284,846; Zerene; DEA No. 2781; C17H15N5O; CHEBI:10102; AC1L1KZH; L-846; 151319-34-5; UNII-S62U433RMH; Bio-0542; SKP-1041; CID5719; AKOS000280863; N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide; I06-0419; LJC-10846; AC-2082; DB00962; SMR000238180; CPD000238180; C07484; CL-284846; Zaleplon (JAN/USAN/INN); Zaleplon [USAN:INN]; ZAL 846; NCGC00160525-01; L 846; Acetamide, N-(3-(3-cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)phenyl)-N-ethyl-; MolPort-000-883-860; L846; Zalaplon; Staccato-zaleplon
Trade NameSonata; Starnoc
CompanyKing Pharm
IndicationInsomnia
[ICD9: 307.41, 307.42, 327.0, 780.51, 780.52   ICD10: F51.0, G47.0]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-
18)11-20-22(16)17/h4-9,11H,3H2,1-2H3
InChIKeyHUNXMJYCHXQEGX-UHFFFAOYSA-N
Canonical SMILESCCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C    
Therapeutic ClassHypnotics and Sedatives
CAS NumberCAS 151319-34-5
FormulaC17H15N5O
PubChem Compound IDCID 5719.
PubChem Substance IDSID 9687.
SuperDrug ATC IDN05CF03
SuperDrug CAS ID151319345;
TargetOmega 1 Benzodiazepine receptorAgonist[2][3][4]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 077237 To Reference
Ref 2Acute intoxication with zaleplon--a case report. Przegl Lek. 2007;64(4-5):310-1. To Reference
Ref 3Binding and neuropharmacological profile of zaleplon, a novel nonbenzodiazepine sedative/hypnotic. Eur J Pharmacol. 2002 Jan 2;434(1-2):21-8. To Reference
Ref 4Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol. 2002 Sep 13;451(2):103-10. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543